Skye Bioscience Files 8-K Amendment, Announces Effective Date for Rights Change

What Happened
Skye Bioscience, Inc. (SKYE) filed an amendment to its Form 8-K (Item 3.03) on August 20, 2026 to announce the Effective Date for a material modification to the rights of its security holders that was originally disclosed in a Form 8-K filed on August 14, 2026. The amendment states it is being filed solely to announce the Effective Date; otherwise, the Original Form 8-K remains unchanged.

Key Details

• Item reported: 3.03 — Material Modification to Rights of Security Holders.
• Original disclosure filed: August 14, 2026.
• Amendment filed: August 20, 2026 — filed solely to announce the Effective Date.
• The amendment says capitalized terms have the meanings set forth in the Original Form 8-K and that no other changes were made.

Why It Matters
A material modification to security holders' rights can affect voting, conversion, transferability, or other legal/economic rights tied to the company’s securities. This amendment signals that the change has reached its Effective Date, so investors and holders should review the August 14, 2026 Form 8-K (and any related documents) to understand the specific changes and their potential impact. Consider consulting the filed 8-K exhibits or seeking financial/legal advice for how the modification may affect your holdings.